These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 19150337

  • 41. In the presence of phospholipids, glycosaminoglycans potentiate factor Xa-mediated protein C activation by modulating factor Xa activity.
    McRae SJ, Stafford AR, Fredenburgh JC, Weitz JI.
    Biochemistry; 2007 Apr 03; 46(13):4195-203. PubMed ID: 17343367
    [Abstract] [Full Text] [Related]

  • 42. Co-crystal structure and inhibition of factor Xa by PD0313052 identifies structurally stabilized active site residues of factor Xa and prothrombinase.
    Gould WR, Cladera E, Harris MS, Zhang E, Narasimhan L, Thorn JM, Leadley RJ.
    Biochemistry; 2005 Jul 05; 44(26):9280-9. PubMed ID: 15981994
    [Abstract] [Full Text] [Related]

  • 43. Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation.
    Johnson DJ, Li W, Adams TE, Huntington JA.
    EMBO J; 2006 May 03; 25(9):2029-37. PubMed ID: 16619025
    [Abstract] [Full Text] [Related]

  • 44. TFPIα interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation.
    Wood JP, Petersen HH, Yu B, Wu X, Hilden I, Mast AE.
    Blood Adv; 2017 Dec 26; 1(27):2692-2702. PubMed ID: 29291252
    [Abstract] [Full Text] [Related]

  • 45. Effects of four commercially available factor Xa proteins on the fluorogenic anti-factor Xa assay when monitoring unfractionated heparin.
    Castro-López V, Murray B, Harris LF, O'Donnell JS, Killard AJ.
    Blood Coagul Fibrinolysis; 2012 Jan 26; 23(1):98-103. PubMed ID: 22089943
    [Abstract] [Full Text] [Related]

  • 46. Coagulation factor Xa inhibits cancer cell migration via protease-activated receptor-1 activation.
    Borensztajn K, Bijlsma MF, Reitsma PH, Peppelenbosch MP, Spek CA.
    Thromb Res; 2009 Jun 26; 124(2):219-25. PubMed ID: 19250659
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Protein adsorption on polyurethane catheters modified with a novel antithrombin-heparin covalent complex.
    Du YJ, Brash JL, McClung G, Berry LR, Klement P, Chan AK.
    J Biomed Mater Res A; 2007 Jan 26; 80(1):216-25. PubMed ID: 17072855
    [Abstract] [Full Text] [Related]

  • 50. A loop of coagulation factor VIIa influencing macromolecular substrate specificity.
    Bjelke JR, Persson E, Rasmussen HB, Kragelund BB, Olsen OH.
    FEBS Lett; 2007 Jan 09; 581(1):71-6. PubMed ID: 17182039
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate.
    Glauser BF, Pereira MS, Monteiro RQ, Mourão PA.
    Thromb Haemost; 2008 Sep 09; 100(3):420-8. PubMed ID: 18766257
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Lack of increase or reduction in circulating platelet factor 4 and heparin-releasable platelet factor 4 in symptomatic patients with asthma.
    Luzzatto G, Cella G, Boschetto P, Fabbri L.
    J Lipid Mediat; 1993 Jun 09; 7(2):151-4. PubMed ID: 8400116
    [Abstract] [Full Text] [Related]

  • 56. Mass Spectrometry Reveals a Multifaceted Role of Glycosaminoglycan Chains in Factor Xa Inactivation by Antithrombin.
    Minsky BB, Abzalimov RR, Niu C, Zhao Y, Kirsch Z, Dubin PL, Savinov SN, Kaltashov IA.
    Biochemistry; 2018 Aug 14; 57(32):4880-4890. PubMed ID: 29999301
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Antithrombotic potential of GW813893: a novel, orally active, active-site directed factor Xa inhibitor.
    Abboud MA, Needle SJ, Burns-Kurtis CL, Valocik RE, Koster PF, Amour AJ, Chan C, Brown D, Chaudry L, Zhou P, Patikis A, Patel C, Pateman AJ, Young RJ, Watson NS, Toomey JR.
    J Cardiovasc Pharmacol; 2008 Jul 14; 52(1):66-71. PubMed ID: 18645410
    [Abstract] [Full Text] [Related]

  • 60. Anticoagulant mechanism of factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis.
    Ishikawa M, Kumashiro M, Yamazaki Y, Atoda H, Morita T.
    J Biochem; 2009 Jan 14; 145(1):123-8. PubMed ID: 18977769
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.